- Open Access
No influence of oxygen levels on pathogenesis and virus shedding in Salmonid alphavirus (SAV)-challenged Atlantic salmon (Salmo salar L.)
© Andersen et al; licensee BioMed Central Ltd. 2010
- Received: 4 June 2010
- Accepted: 21 August 2010
- Published: 21 August 2010
For more than three decades, diseases caused by salmonid alphaviruses (SAV) have become a major problem of increasing economic importance in the European fish-farming industry. However, experimental infection trials with SAV result in low or no mortality i.e very different from most field outbreaks of pancreas disease (PD). This probably reflects the difficulties in reproducing complex biotic and abiotic field conditions in the laboratory. In this study we looked at the relationship between SAV-infection in salmon and sub-lethal environmental hypoxia as a result of reduced flow-through in tank systems.
The experiment demonstrated that constant reduced oxygen levels (60-65% oxygen saturation: 6.5-7.0 mg/L) did not significantly increase the severity or the progress of pancreas disease (PD). These conclusions are based upon assessments of a semi-quantitative histopathological lesion score system, morbidities/mortalities, and levels of SAV RNA in tissues and water (measured by 1 MDS electropositive virus filters and downstream real-time RT-PCR). Furthermore, we demonstrate that the fish population shed detectable levels of the virus into the surrounding water during viraemia; 4-13 days after i.p. infection, and prior to appearance of severe lesions in heart (21-35 dpi). After this period, viral RNA from SAV could not be detected in water samples although still present in tissues (gills and hearts) at lasting low levels. Lesions could be seen in exocrine pancreas at 7-21 days post infection, but no muscle lesions were seen.
In our study, experimentally induced hypoxia failed to explain the discrepancy between the severities reported from field outbreaks of SAV-disease and experimental infections. Reduction of oxygen levels to constant suboptimal levels had no effect on the severity of lesions caused by SAV-infection or the progress of the disease. Furthermore, we present a modified VIRADEL method which can be used to detect virus in water and to supplement experimental infection trials with information related to viral shedding. By using this method, we were able to demonstrate for the first time that shedding of SAV from the fish population into the surrounding water coincides with viraemia.
- Atlantic Salmon
- Salmo Salar
- Indirect Fluorescence Antibody Test
- Infectious Salmon Anaemia Virus
- Infectious Pancreatic Necrosis Virus
Diseases caused by salmonid alphaviruses; SAV (Alphavirus, Togaviridae) have become an increasing problem of economical importance to the European fish-farming industry. Salmonid alphavirus (SAV) is the only alphavirus that has been isolated from fish, and are thought to comprise at least six subtypes (SAV1-6) . Whereas all subtypes have been associated with pancreas disease (PD) affecting Atlantic salmon (Salmo salar L.) in sea water , SAV2 is the only subtype that is known to cause disease outbreaks in fresh water, i.e in rainbow trout Oncorhynchus mykiss (Walbaum) [1–6]. In Norway, SAV3 is the only identified subtype [6–8], and the virus has been shown to affect sea water reared rainbow trout and salmon [9, 10].
During PD-outbreaks, affected fish will often exhibit abnormal swimming behaviour and may congregate in net pen corners close to the surface . Affected fish may seem lethargic with a marked loss in appetite. Few if any distinctive gross pathological changes can be seen during experimental SAV-infections. Histopathological findings associated with infections by all subtypes of SAV are very similar [11, 12], and may include severe degeneration of exocrine pancreas together with myopathy of heart- and skeletal muscle, with variable inflammation. These significant lesions occur in a sequential manner, with pancreas being the first tissue showing pathology, followed by lesions in heart and skeletal muscle [13, 14].
Mortality rates associated with SAV-infections in sea water reared salmon and rainbow trout are highly variable [10, 15, 16] and range from subclinical infections with no outbreaks  to acute outbreaks with high mortality [1, 10, 18]. The severity of PD in sea water can be affected by a range of factors linked to the environment, pathogen and/or the host such as stressors related to handling, management strategies, other infectious agents [19–21] temperature  and differences in genetic factors related to the host or the virus (virulence traits) [15, 22–24]. In experimental trials with SAV, however, high mortalities are rarely seen [4, 18, 22, 25–28] probably due to problems with reproducing complex field conditions in the laboratory.
Our understanding on how variations in water temperature, oxygen and salinity levels might influence fish welfare and susceptibility for infectious diseases is limited [29, 30]. In general, hypoxia has a negative impact on important mechanisms such as growth, appetite, disease resistance and welfare of salmon . Shortage of oxygen (hypoxia) can act as a stressor to fish  and elicit primary stress responses such as release of catecholamines and corticosteroids (see [33, 34]) possibly affecting immune responses which renders the fish more susceptible to infections [32–34]. Fish reared in marine net pens/large cage systems experience periods with environmental hypoxia, especially during rapid growth in combination with high stocking densities and high temperatures . Also, oxygen levels within a fish farm may fluctuate with depth and time and within and between sea-cages and due to shifting changes in environmental factors such as water currents, wind, temperature, salinity, oxygen mixing and oxygen production by photosynthetic algae (see ). Experimental trials where Atlantic salmon were repeatedly exposed to graded hypoxia have shown that fluctuations between normoxia and 60-65% oxygen saturation is suboptimal for salmon, whereas fluctuations between normoxia and 50% saturation or less have been shown to affect appetite in a negative manner and lead to an increased number of skin lesions and elevation of stress responses (Mette Remen, IMR, Bergen, Norway, personal communication). In our study, we wanted to see if by reducing oxygen levels to constant environmentally sub-lethal levels (60-65%) this would affect the development and/or the severity of SAV-infection/PD. This was assessed by measuring levels of SAV in tissues and in water (shedding of virus) by real-time RT-PCR, and by comparing histopathological lesions (heart, pancreas and somatic muscle) and mortalities between the respective groups.
Fish and experimental design
Fish were supplied by a local fish supplier (Hordaland County) and reared at the fish facility at Industrilaboratoriet (ILAB) located at Bergen High Technology Centre, Norway. Prior to the experiment, gills from 30 fish were screened by real-time RT-PCR for the presence of various disease causing agents (SAV, infectious pancreatic necrosis virus (IPNV), infectious salmon anaemia virus (ISAV), Chlamydia sp., Neoparamoeba sp., Paranucleospora theridion, and Parvicapsula sp.) with negative results. The fish had a mean weight of 73.2 grams and a mean length of 18.1 cm (n = 30) at the beginning of the experiment and had been vaccinated with a multivalent vaccine (no SAV component). Initially, the fish were reared in fresh water in a flow-through system. The fish group were then exposed to an increasing salinity level (particle filtered (50 μm) and UV-sterilized (> 60 mW/cm2 ) sea water), experiencing full salinity 33‰ (mean 31.97‰, range 30.3-32.8‰) and 12 °C (mean 11.95 °C, range 11.6-12.9°C) five weeks prior to the experiment. Salinity, oxygen levels and temperature were monitored at least daily throughout the experiment, and the fish were hand fed daily with a commercial feed. The flow-through in tanks was from 100-400 Lh-1tank-1 dependent on desired oxygen levels for the various experimental groups (60-65% - or 85-90% saturation) and according to biomass and temperature. Two hundred and sixty fish were divided into 4 tanks (0.15 m3), n = 65 fish per tank. When the experiment started the fish groups had been acclimatized to laboratory conditions for 55 days. The experiment was approved by the Norwegian Animal Research Authorities (NARA) in 2008 (reference number 899).
Supernatants from Chinook salmon embryo (CHSE-214) cell culture (uninfected or salmonid alphavirus (SAV)-infected) were diluted 1:10 in Eagle's Minimum Essential Medium (EMEM) and sterile filtered. Two control groups (2 tanks, n = 65 per tank) were intraperitoneally (i.p.) injected with 0.2 ml of supernatants from uninfected cells whereas two other groups (2 tanks, n = 65 per tank) were i.p. injected with 0.2 ml of supernatants from SAV-infected cells, prepared as described. The SAV-isolate was a SAV subtype 3 isolate; SAVH30/04 (kindly provided by M. Karlsen, University of Bergen). All fish were anaesthetized with Metacaine MS-222 prior to injection. The SAV3 isolate SAVH30/04, originating from salmon in Hordaland county in 2004, had been passed six times in CHSE-214 cell culture until cytopathogenic effect (CPE) could be observed (10 dpi), and had a viral endpoint titer TCID50 of 5.6 × 104 virus per ml in the inoculum.
Virus end point-titration by indirect fluorescence antibody test (IFAT)
Virus end point-titration was based upon the method described by Kärber  and was used to estimate the 50% tissue culture infectious dose (TCID50) of the inoculum. Briefly, a ten fold dilution series of the inoculum in medium with 2% Fetal Bovine Serum (FBS) was prepared and inoculated onto rainbow trout (RT)-gill cells grown in a 96-well plate and incubated for 8 days at 14°C. The IFAT procedure was performed as described by  but with primary recombinant polyclonal antibodies E2-pTe200 raised against SAV3 (1:400). A panel of four polyclonal recombinant antibodies were generated in 2005 (Karl F. Ottem & Katrine Bones Enger, University of Bergen, unpublished) by immunizing rabbits with SAV3-derived recombinant antigens (E1 and E2-region) expressed in Escherichia coli, and one of these was used in this study (E2-pTe200)(courtesy of KF. Ottem, University of Bergen). The cells were incubated with a secondary antibody, Alexa Fluor 488 goat anti-rabbit IgG (1:1000 dilution, Molecular probes) and examined in a Leica DMIRBE inverted fluorescence microscope. Cells that had been inoculated with cell media only acted as negative controls.
Two days after SAV-infection, the oxygen levels in two of the tanks (parallel tanks; one uninfected control group and one SAV-infected) were gradually lowered (during the first 24 h period) from normal oxygen conditions (85-90% oxygen saturation, 9.2-9.7 mg O2 per liter, approx. 300-400 Lh-1tank-1) to constant suboptimal/sub-lethal conditions (60-65% oxygen saturation, 6.5-7.0 mg O2 per liter, approx. 100-200 Lh-1tank-1) by slowly reducing flow-through in the tanks. The oxygen levels were monitored closely in the beginning, and then at least daily throughout the experimental period of 70 days. The flow-through was adjusted according to biomass during the experiment in order to keep the oxygen levels at a constant reduced level of 60-65% saturation.
The experimental groups are hereafter throughout the manuscript referred to as CNorm and CRed for the uninfected controls reared at normal and reduced oxygen levels, whereas the SAV-infected groups held under normal and reduced oxygen will be referred to as SNorm and SRed, respectively.
Sampling of tissues
At various times post SAV-infection (7, 14, 21, 35, 49 and 70 days post infection), tissues were sampled from five fish from each experimental group (CNorm, CRed, SNorm and SRed). Fish were killed by a blow to the head, and blood was taken from the caudal veins into heparinised tubes. Weight/fork length together with gross pathology were noted for all individuals. Fulton's condition factor (K) was calculated by K = W (weight in grams)/L (length in cm)-3 * 100. The samples were kept on ice or fast frozen in liquid nitrogen for real-time RT-PCR (gills and hearts), and fixed by immersion in a modified Karnovsky's fixative for histology (heart, somatic muscle at the level of the lateral line and the dorsal fin, together with pyloric caeca region and spleen with pancreatic tissue). Blood was centrifuged at 1000 × g for 5 min and plasma was removed and frozen at -80°C for subsequent SAV RNA real-time RT-PCR measurements. Gills from dead and moribund fish were also analyzed with real-time RT-PCR. In addition, pancreatic tissue, heart and muscle were also processed for histology from moribund fish.
Inocula from head kidney of all individuals were plated onto Difco™ Marine Agar 2216 and blood agar supplemented with 1.5% NaCl. Agar was incubated at 15°C until colonies could be seen, or discarded after 14 days if no colonies appeared. Colonies were cultivated in Difco™ Marine Broth 2216 for 24-48 h and frozen in this media with 20% glycerol at -80°C for long term storage of bacteria stock. DNA was extracted from bacteria by resuspending a single colony in 50 μl of destH20, vortexing, heating at 95°C for 5 min and centrifuging at 12000 × g for 1 min. One μl of the resulting supernatant containing DNA was used as a template in a PCR reaction; 5 μl of 10 × ExTaq buffer (TaKaRa), 4 μl of 10 mM dNTP's, 1 μl of forward and reverse primers targeting the 16 S rRNA gene of a broad spectra of bacteria; EUGB27F (5'-AGAGTTTGATCMTGGCTCAG-3') and EUG1518R (5'-AAGGAGGTGATCCANCCRCA -3') , 0.3 μl of Ex Taq polymerase (TaKaRa), to a total volume of 50 μl. The PCR was run under the following conditions; an initial denaturing at 94°C for 3 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing 52°C for 45 s, elongation 72°C for 2 min, followed by a final elongation stage of 72°C for 10 min. PCR-products were evaluated on a 1% agarose gel in 1 × Tris-acetate-EDTA (TAE) buffer and products were sequenced directly in both directions by the use of a ABI Prism BigDye™ Terminator Cycle Sequencing Ready Reaction kit, version 3.1 (Applied Biosystems, Perkin-Elmer) according to the manufacturers instructions, with the primers EUGB27F or EUG1518R and analyzed at the sequence facility at Bergen High Technology Centre. The sequences were processed using Vector NTI Contig suite version 9.0.0 (Informax) and identified using BLAST.
Exogenous control for real-time RT-PCR analysis of plasma and water samples
Two exogenous controls or spikes were used in this study in order to quantify SAV-specific viral RNA levels in water or plasma; the extreme halophile Halobacterium salinarum (an archaeon) (type strain DSM 3754/ATCC 33171) and the aquatic rhabdovirus Viral Haemorrhagic Septicaemia Virus (VHSV). The VHSV virus isolate was of genotype III and had been isolated from rainbow trout in Norway in 2008 , and given the name FA28.02.08 (Genbank acc.# GU121099 and GU121100). H. salinarum was cultivated at 37°C in medium 97 from DSMZ to an optical density OD600 nm of 2.0. VHSV was cultivated at 14°C in RT-gill cells for two passages until appearance of CPE and with a viral endpoint titer of 1 × 107 virus per ml. Virus supernatants (sterile filtered) and H. salinarum in its medium were aliquoted at these concentrations and frozen at -80°C for subsequent spiking of samples. Plasma samples (25 μl) were added 4 μl of VHSV prior to RNA extraction. For water samples, the H. salinarum spike was added prior to filtration (20 μl per liter) as a filtration control, whereas VHSV was added after filtration as a RNA extraction control (4 μl per 350 μl sample of lysis buffer-see next section).
One liter of sea water was sampled from the respective fish tanks in sterile autoclaved screw-cap bottles (Nunc). Sampling was done at the following time points after SAV infection; 6, 13, 20, 28, 37 and 69 dpi for all tanks. In addition, in order to obtain more detailed information about the onset and duration of the virus shedding period, water from the CNorm and SNorm groups were monitored more closely than CRed and SRed, with water sampling at 2, 4, 8, 10, 15, 17 and 22 days post SAV-infection.
Water filtration for viruses was done according to a VIRADEL (virus-adsorption-elution) method (see [40, 41]) using electropositive 1 MDS filters [42, 43]. Filtration was done following the instructions made by the manufacturer, with some modifications. Briefly, one liter of sea water was vacuum filtered through one-layer of electropositive Zeta Plus® Virosorb® 1 MDS Filters (Cuno Inc, U.S.A.) with a glass filtration system for 47 mm diameter membranes (Pyrex®Laboratory Glassware, U.K) with a water flow of 0.2-0.5 liters per min, after adding 20 μl of H. salinarum (see previous section). The filters were placed upside down in 1.4 ml of lysis buffer (E.Z.N.A total RNA kit from OmegaBioTek) in 50 mm diameter petri dishes, sealed with parafilm and shaken for 10 minutes (150 rpm) at room temperature. Two portions (à 350 μl) of lysis buffer were removed and 4 μl of VHSV was added to one of these portions (the other portion acted as a VHSV-negative control). The samples were each mixed with 350 μl 70% EtOH, vortexed and frozen at -80°C prior to subsequent thawing and RNA extraction following the manufacturer's protocol using the E.Z.N.A total RNA kit from OmegaBioTek. This modified method was evaluated prior to use and resulted in at least a 20 fold concentration of viral RNA compared to unfiltered (unconcentrated) samples, and was highly reproducible (data not shown).
RNA extraction and real-time RT-PCR
Total RNA was extracted from tissues (gills and hearts 10-20 μg) using TRIreagent (Sigma) according to the method described by Devold and coworkers , whereas total RNA were extracted from serum samples (25 μl) with the E.Z.N.A total RNA kit from OmegaBioTek following the manufacturer's protocol. The RNA was eluted in 50 μl of DEPC treated H20 water. The Verso™ 1-step QRT-PCR Rox kit from Thermo Scientific was used for real-time RT-PCR analysis. The nsP1-assay targeting the nsP1-gene in SAV  was applied for specific detection of SAV, whereas the elongation factor 1 alpha (EF1AA) assay  were used as an endogenous control for tissues. The VHSV08-assay targeting VHSV  and the Sal-assay targeting H. salinarum (present study; F-primer: 5'-GGGAAATCTGTCCGCTTAACG-3', R-primer: 5'- CCGGTCCCAAGCTGAACA-3', Probe: VIC-5'- AGGCGTCCAGCGGA-3'-MGB) was used as exogenous controls when extracting RNA from plasma and water samples. The Sal-assay generates a 59 bp PCR-product (position 541-600 of Acc.# AB219965). The real-time master mixture consisted of 6.25 μl 1-step QPCR Rox Mix (2 ×), 0.625 µl RT Enhancer, together with 0.125 µl of Verso Enzyme mix. Primer and probe concentrations had been optimized for each assay; F primer/R primer/probe: nsP1 assay (SAV): 900 nm/900 nm/200 nm, EF1AA assay (elongation factor 1 alpha); 900 nm/900 nm/225 nm), Sal assay: 300 nm/900 nm/200 nm, VHSV08 assay: 600 nm/600 nm/225 nm. Primers and probes at their respective concentrations were added to the master mixture and adjusted with ddH20 to a total volume of 10.5 µl prior to adding 2 µl of RNA template. The real-time RT-PCR reaction was run in a 7500 Fast Real-Time PCR System cycler from Applied Biosystems using the following conditions: reverse transcription at 50°C for 15 minutes followed by activation of the Thermo-Start DNA polymerase at 95°C for 15 minutes prior to amplification with 45 cycles of 95°C for 15 seconds and 60°C for 1 min (denaturation and annealing/extension). For each assay a standard curve was generated from dilution series of RNA in 20 ng/μl yeast tRNA (Invitrogen) (nsP1-, EF1AA- and Sal-assays) or ddH20 (VHSV-assay).
All samples that were analyzed with real-time RT-PCR were performed in triplicate. Only samples that were positive in triplicates were considered for normalization. Thresholds for all assays were set to 0.01 except for the Sal-assay which was set to 0.001. Ct-values obtained for the target gene (nsP1-assay) were normalized against the endogenous control EF1AA-assay (tissues) whereas plasma samples were normalized against the VHSV08-assay. Water samples were normalized against both the Sal-assay and the VHSV08-assay. Samples from dead fish were not normalized, but only considered as SAV-positive or SAV-negative. RNA extraction controls and no template controls (NTC) were included in all runs in order to detect possible contamination. In addition, a positive control was included in all runs in order to detect reagent mix errors. If water or plasma samples were found SAV-positive, one parallel sample that had not been spiked with VHSV was also checked for the presence of VHSV that could have given rise to false background for normalization of real-time RT-PCR data (VHSV-negative controls).
Mean Ct-values for the target gene nsP1 were normalized against endogenous (EF1AA)- and exogenous reference genes (Sal- and VHSV-assays) by the use of the Microsoft®Excel® based computer software Q-Gene . The resulting mean normalized expression (MNE)-values were transformed into N-folds by defining the lowest MNE valued obtained during the experiment for each tissue as 1. The data were then Log2 transformed. In order to evaluate if there were any significant differences in the normalized RNA levels of samples from the SNorm and the SRed groups, Log2 values for each sample from both groups at the various sampling points were imported into the GraphPad Prism 5.00 software; GraphPad Software, Inc., San Diego, CA. Statistical differences in viral RNA levels in plasma, water, gills and hearts between groups were evaluated by a Kruskal-Wallis non-parametric test followed by Dunn's post test. The same test were also used for evaluating differences in weight, length and condition factor between groups, whereas the Fisher's exact test were used to evaluate mortality levels between groups. A p-value of 0.05 or less was considered as significant.
Histology and histological scoring system
Semi-quantitative score system for comparing lesion severity between tissues.
Focal pancreatic acinar cell degeneration ± inflammation
Multifocal degeneration/atrophy of pancreatic acinar tissue, plus some normal tissue left ± inflammation
Significant multifocal degeneration/atrophy of pancreatic acinar tissue, no normal tissue left ± inflammation
Focal myocardial degeneration and/or inflammation (< 50 fibres affected)
Multifocal myocardial degeneration ± inflammation (50-100 fibres affected)
Severe diffuse myocardial degeneration ± inflammation (> 100 fibres affected)
Focal myocytic degeneration ± inflammation
Multifocal myocytic degeneration ± inflammation
Severe diffuse myocytic degeneration± inflammation
Real-time RT-PCR standard curves and efficiencies
Standard curve evaluation of the various assays.
Several bacteria were isolated on marine agar and blood agar (2% NaCl) from head kidney of salmon during this experiment. By BLAST search tool the bacteria were identified to genus and it was established that they all belonged to marine genera; Idiomarina sp., Cobetia marina, Janibacter sp., Bacillus sp., Tenacibaculum/Flavobacterium, Vibrio sp., Vibrio splendidus, and Pseudoalteromonas sp.
Two days after infection, the oxygen levels in one tank with uninfected fish (CRed) and one tank with SAV-infected fish (SRed), were gradually (slowly within a 24 h period) lowered from 85-90% saturation (9.2-9.7 mg O2 per liter, approx. 300-400 lh-1tank-1) to 60-65% saturation (6.5-7.0 mg O2 per liter, approx. 100-200 lh-1tank-1) by reduction of the flow-through rate. The average oxygen level during the experiment in the various experimental tanks was; CNorm; mean 86.29 (min 80, max 94), CRed; mean 64.79, (min 52, max 71), SNorm; mean 84.32 (min 69, max 93), SRed; mean 65.57 (min 57, max 75), respectively.
Clinical signs and gross pathological changes
Variable degrees of fin erosions (sometimes with bleedings), especially of the dorsal and pectoral fins, could be seen in all experimental groups throughout the study. Some individuals also had petecchial bleedings/erythemia on abdomen and at pectoral fin bases, and four dead fish had severe erosions behind pectoral fins (CRed and SRed groups).
Weight and length development (condition factor)
During the 70 days the experiment lasted, it was not possible to see a significant increase in mean body length or weight for the fish groups, nor a considerable difference in mean weight, length or Fulton's condition factor (K) between the various groups (see additional files 1, 2 and 3).
SAV in blood
SAV levels in gills and hearts
Levels of SAV-specific viral RNA (nsp1-assay) in water.
Log2 MNE nsP1 vs. Sal (VHSV) in water
Lesions in pancreatic- and heart tissue were only observed in SAV3-challenged fish. The exception was small foci with epicarditis in hearts, which could be found in 11 out of 43 fish (25.6%) of the examined individuals from the control groups. No muscle lesions were found in any of the experimental groups throughout the study. Two moribund fish were sampled from CNorm at 56 and 62 dpi, and one fish from SRed at 42 dpi. Pancreas, heart and muscle tissue were processed for histology and examined, with no lesions recorded in these organs.
Summary of score lesions (histopathological findings) from heart tissue.
Days post infection
(1.6 ± 0.9)
(2 ± 1.4)
(2.2 ± 0.5)
(0.4 ± 0.9)
(0.4 ± 0.9)
(1.2 ± 1.1)
(2.4 ± 1.3)
(2.2 ± 0.5)
A large discrepancy exists between the high mortality levels often reported with pancreas disease (PD) in field versus experimental infections with SAV. It is possible that certain key environmental factors, such as oxygen levels, might play an important role concerning the severity or the progress of PD. In general, hypoxia can act as a stressor to fish  which may result in impaired immune functions mediated through the hypothalamo-pituitary-interrenal axis and lead to decreased resistance to infections [48, 49]. In our study, mortality could not be linked directly to the oxygen levels since similar mortality levels could be seen in all experimental groups. Furthermore, the development or progress of PD was not affected by oxygen levels as lesions of comparable severity were seen during the same time period in both SAV-groups. It is possible that by subjecting fish to constant sub-lethal oxygen levels as performed in this trial, the fish probably experienced a lower stress level and were able to acclimatize to the hypoxic conditions. If the salmon had been repeatedly exposed to fluctuating oxygen levels and not constant suboptimal levels, it is possible that this would have affected the disease progress or led to higher mortality levels (i.e added stress). Exposure of fish to hypoxic conditions for a longer time prior to SAV-infection than was used in this study could have rendered the fish more susceptible to SAV-infection. Moreover, it can not be excluded that the virus infection route could have an impact on mortality levels, as this has been seen for another salmon virus, IPNV, a feature which was attributed to the immune system being activated in different ways .
The SAV-infection led to severe lesions in hearts during the course of infection, characterized by epicarditis and multifocal degeneration of cardiomyocytes in ventricle of the heart. Ferguson et al  concluded that the most severe lesions associated with PD were myocardial degeneration. In our study, in addition to severe lesions in hearts, lesions in exocrine pancreas could also be seen at 7-21 dpi, whereas no lesions could be seen in skeletal muscle during the experiment. It is possible that the absence of muscle lesions in many experimental studies could explain the lower mortality levels reported from experimental SAV-infections, as muscle lesions have been suggested as a contributing factor to PD-mortality in field . Furthermore, muscle lesions in the oesophagus have been reported from PD-cases [51, 52], a feature which probably has the potential to interfere with food intake. Nevertheless, the presence of muscle lesions is probably not the single reason for the discrepancy in mortality levels, since experimental SAV-studies have been described where muscle lesions were induced but with no mortality observed [4, 28].
Salmon has been shown to produce protective neutralizing antibodies shortly after i.p infection , readily diminishing viruses from the system. SAV-specific viral RNA was shown to be present in tissues (gills and hearts) at lasting low levels after the acute phase and throughout the experimental period of 70 days. Such long-lasting presence of SAV-specific viral nucleic acids in tissues have previously been described by Christie et al  (140 days) and by Andersen et al  (190 days) during experimental infections, and also in longitudinal field studies [16, 54]. The nature of these SAV-specific RNAs has not been determined [28, 45]. A few fish from the control groups were shown to be SAV-positive (heart tissue) in this study, which might be due to carrier status as presence of SAV in the fresh water phase has been shown [55, 56].
This study extends the current knowledge of SAV-pathogenesis in Atlantic salmon since it is the first to demonstrate virus shedding during infection. The present study also shows that virus shedding coincides with viraemia. Atlantic salmon Salmo salar L. smolts that were intraperitoneally (i.p.) infected with a salmonid alphavirus (SAV3) isolate (SAVH30/04) shed detectable levels of virus into the surrounding water in the period 4-13 days post infection. This was assessed by a VIRADEL (virus-adsorption-elution) method using electropositive 1MDS virus filters (see [40–43]). The VIRADEL method was optimized for downstream real-time RT-PCR and this modified method has proven to be a very useful tool which can supplement experimental infection trials with information related to viral shedding. Also, this method has a potential for simultaneous detection and monitoring of levels of other pathogens, as such abilities have been demonstrated for electropositive 1MDS filters . Detection of infectious SAV-particles in water samples can also be monitored by inoculation onto susceptible cell cultures after viruses have been eluted from filters with cell medium containing sera. We further demonstrate that the highest levels of SAV-specific viral RNA shed to the water could be seen at 6 days post infection in both SAV-infected groups. This coincided with the period where the highest SAV viral RNA levels could be seen in plasma (7 dpi) and gills in both SAV-groups. Both infectious SAV-particles/viral RNA have been shown to only be present in blood for a relative short period after infection . The presence of viral RNA in plasma as soon as 7 dpi is suggestive of a rapid onset of viraemia after i.p. injection of virus, as reported for other experimental i.p. infections with SAV [22, 27, 28, 57]. In tissues, the highest viral RNA levels specific for SAV could be seen at 7 dpi in gills and at 14 dpi in hearts, respectively. In general, the viral RNA levels seemed higher in hearts than in gills. However, no significant differences were found between the SAV-infected groups regarding viral RNA levels in tissues or water, suggesting that oxygen levels did not have a considerable effect on the infection. In our study, detectable levels of virus shedding preceded appearance of severe lesions in heart which could be seen from 21 -35 days after i.p. infection. Viral shedding from a SAV-infected fish population in a farm, however, will be a more complex situation, as the time period where viral shedding can be seen will be more prolonged and not a synchronous event as seen in experimental tank systems. In addition, information is lacking regarding the route of virus entry/exit and the virus dose necessary to elicit an infection. Our findings that SAV shedding coincides with blood viraemia further supports the proposal of Graham and coworkers  that in order to detect or monitor an active SAV-infection in a given salmon population, blood serum or plasma should be monitored in addition to the previously recommended tissues for real-time RT-PCR diagnostics; pseudobranch/gills and hearts [45, 54].
In the present study, experimentally induced hypoxia failed to explain the discrepancy between the severities reported from field outbreaks of PD-disease and experimental infections as the severity or the progress of the disease was not affected. We also demonstrate for the first time by the use of a modified VIRADEL method that detectable levels of SAV are shed into water during viraemia.
The authors are grateful to the Lauritz Meltzer fund at the University of Bergen for funding this project, and would also like to thank all persons involved in sampling of fish. The employees at ILAB are appreciated for carefully monitoring and adjusting oxygen levels. We are also grateful for being able to use the polyclonal antibodies against SAV3 developed at the University of Bergen in 2005 by Karl F. Ottem. Kuninori Watanabe, Department of Biology, University of Bergen, is valued for advice on histology preparation and Paul Løvik (same Department) for autoclaving and microscopy assistance. Dr. Petter Frost at Schering Plough-Intervet Norbio, Bergen, is appreciated for valuable inputs, whereas Mette Remen at the Institute of Marine research, IMR, Bergen, Norway, is valued for sharing unpublished results from fish experiments concerning hypoxia. We also thank Lindsey Moore at Schering Plough-Intervet Norbio, Bergen, for proofreading the manuscript.
- Fringuelli E, Rowley HM, Wilson JC, Hunter R, Rodger H, Graham DA: Phylogenetic analyses and molecular epidemiology of European salmonid alphaviruses (SAV) based on partial E2 and nsP3 gene nucleotide sequences. J Fish Dis 2008, 31: 811-823. 10.1111/j.1365-2761.2008.00944.xPubMedView ArticleGoogle Scholar
- Castric J, Baudin Laurencin F, Bremont M, Jeffroy J, Le Ven A, Bearxotti M: Isolation of the virus responsible for sleeping disease in experimentally infected rainbow trout ( Oncorhynchus mykiss ). Bull Eur Ass Fish Pathol 1997,17(1):27-30.Google Scholar
- Villoing S, Béarzotti M, Chilmonczyk S, Castric J, Brémont M: Rainbow trout sleeping disease virus is an atypical alphavirus. J Virol 2000,74(1):173-183. 10.1128/JVI.74.1.173-183.2000PubMedPubMed CentralView ArticleGoogle Scholar
- Weston J, Villoing S, Bremont M, Castric J, Pfeffer M, Jewhurst V, Mcloughlin MF, Rødseth O, Christie KE, Koumans J, Todd D: Comparison of two aquatic alphaviruses, salmon pancreas disease virus and sleeping disease virus, by using genome sequence analysis, monoclonal reactivity, and cross-infection. J Virol 2002, 76: 6155-6163. 10.1128/JVI.76.12.6155-6163.2002PubMedPubMed CentralView ArticleGoogle Scholar
- Graham DA, Rowley HM, Walker IW, Weston JH, Branson EJ, Todd D: First isolation of sleeping disease virus from rainbow trout, Oncorhynchus mykiss (Walbaum), in the United Kingdom. J Fish Dis 2003, 26: 691-694. 10.1046/j.1365-2761.2003.00505.xPubMedView ArticleGoogle Scholar
- Weston JH, Graham DA, Branson E, Rowley HM, Walker IW, Jewhurst VA, Jewhurst HL, Todd D: Nucleotide sequence variation in salmonid alphaviruses from outbreaks of salmon pancreas disease and sleeping disease. Dis Aquatic Organ 2005, 66: 105-111. 10.3354/dao066105View ArticleGoogle Scholar
- Hodneland K, Bratland A, Christie KE, Endresen C, Nylund A: New subtype of salmonid alphavirus (SAV), Togaviridae , from Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss in Norway. Dis Aquat Organ 2005, 66: 113-120. 10.3354/dao066113PubMedView ArticleGoogle Scholar
- Karlsen M, Hodneland K, Endresen C, Nylund A: Genetic stability within the Norwegian subtype of salmonid alphavirus (family Togaviridae). Arch Virol 2006,151(5):861-74. 10.1007/s00705-005-0687-6PubMedView ArticleGoogle Scholar
- Olsen AB, Wangel C: An outbreak of PD-like disease in rainbow trout ( Oncorhynchus mykiss ) in Norway [abstract]. Book of Abstracts EAFP 8th International Conference, 14-19 sept., Edinburgh, Scotland 1997, 62.Google Scholar
- Taksdal T, Olsen AB, Bjerkås I, Hjortaas MJ, Dannevig BH, Graham DA, McLoughlin MF: Pancreas disease in farmed Atlantic salmon, Salmo salar L., and rainbow trout, Oncorhynchus mykiss (Walbaum), in Norway. J Fish Dis 2007, 30: 545-558. 10.1111/j.1365-2761.2007.00845.xPubMedView ArticleGoogle Scholar
- Boucher P, Baudin-Laurencin F: Sleeping disease and pancreas disease comparative histopathology and acquired cross-protection. J Fish Dis 1996, 19: 303-310. 10.1111/j.1365-2761.1996.tb00708.xView ArticleGoogle Scholar
- Hodneland K: Salmonid Alphavirus (SAV) - Genetic characterisation of a new subtype, SAV3, and implementation of a novel diagnostic method. In Dr scient thesis. University of Bergen, Department of Biology; 2006.Google Scholar
- Murphy TM, Rodger HM, Drinan EM, Gannon F, Kruse P, Korting W: The sequential pathology of pancreas disease in Atlantic salmon farms in Ireland. J Fish Dis 1992, 15: 401-408. 10.1111/j.1365-2761.1992.tb01239.xView ArticleGoogle Scholar
- McLoughlin MF, Nelson RN, McCormick JI, Rowley HM, Bryson DB: Clinical and histopathological features of naturally occurring pancreas disease in farmed Atlantic salmon, Salmo salar L. J Fish Dis 2002, 25: 33-43. 10.1046/j.1365-2761.2002.00334.xView ArticleGoogle Scholar
- Crockford T, Menzies FD, McLoughlin MF, Wheatley SB, Goodall EA: Aspects of the epizootiology of pancreas disease in farmed Atlantic salmon Salmo salar L in Ireland. Dis Aquat Organ 1999, 36: 113-119. 10.3354/dao036113PubMedView ArticleGoogle Scholar
- Jansen MD, Taksdal T, Wasmuth MA, Gjerset B, Brun E, Olsen AB, Breck O, Sandberg M: Salmonid alphavirus (SAV) and pancreas disease (PD) in Atlantic salmon, Salmo salar L., in freshwater and seawater sites in Norway from 2006 to 2008. J Fish Dis 2010,33(5):391-402. 10.1111/j.1365-2761.2009.01131.xPubMedView ArticleGoogle Scholar
- Graham DA, Jewhurst H, McLoughlin MF, Sourd P, Rowley HM, Taylor C, Todd D: Sub-clinical infection of farmed Atlantic salmon Salmo salar with salmonid alphavirus- a prospective longitudinal study. Dis Aquat Organ 2006,27;72(3):193-9. 10.3354/dao072193View ArticleGoogle Scholar
- McLoughlin MF, Graham DA: Alphavirus infections in salmonids- a review. J Fish Dis 2007,30(9):511-31. 10.1111/j.1365-2761.2007.00848.xPubMedView ArticleGoogle Scholar
- McVicar AH: Pancreas disease of farmed Atlantic salmon, Salmo salar , in Scotland: epidemiology and early pathology. Aquaculture 1987,67(1987):71-78. 10.1016/0044-8486(87)90009-3View ArticleGoogle Scholar
- McVicar AH: Infection as a primary cause of pancreas disease in farmed Atlantic salmon. Bull Eur Ass Fish Pathol 1990,10(3):84-87.Google Scholar
- Nylund S, Sævareid IO, Nylund A: Occurrence and association of a microsporidian with salmon diseases in Norway [abstract]. Book of Abstracts EAFP 14th International Conference, Prague, 14-19 sept 2009, 159.Google Scholar
- McLoughlin MF, Graham DA, Norris A, Matthews D, Foyle L, Rowley HM, Jewhurst H, MacPhee J, Todd D: Virological, serological and histopathological evaluation of fish strain susceptibility to experimental infection with salmonid alphavirus. Dis Aquat Organ 2006, 72: 125-133. 10.3354/dao072125PubMedView ArticleGoogle Scholar
- Norris A, Foyle L, Ratcliff J: Heritability of mortality in response to a natural pancreas disease (SPDV) challenge in Atlantic salmon, Salmo salar L., post-smolts on a West of Ireland sea site. J Fish Dis 2008, 31: 913-920. 10.1111/j.1365-2761.2008.00982.xPubMedView ArticleGoogle Scholar
- Kristoffersen AB, Viljugrein H, Kongtorp RT, Brun E, Jansen PA: Risk factors for pancreas disease (PD) outbreaks in farmed Atlantic salmon and rainbow trout in Norway during 2003-200. Prev Vet Med 2008,90(1.2):127-136.Google Scholar
- Houghton G: Acquired protection in Atlantic salmon Salmo salar parr and post-smolts against pancreas disease. Dis Aquat Organ 1994, 18: 109-118. 10.3354/dao018109View ArticleGoogle Scholar
- McLoughlin MF, Nelson RT, Rowley HM, Cox DI, Grant AN: Experimental pancreas disease in Atlantic salmon Salmo salar post-smolts induced by salmon pancreas disease virus (SPDV). Dis Aquat Organ 1996, 26: 117--124. 10.3354/dao026117View ArticleGoogle Scholar
- Desvignes L, Quentel C, Lamour F, Le Ven A: Pathogenesis and immune response in Atlantic salmon (Salmo salar L.) parr experimentally infected with salmon pancreas disease virus (SPDV). Fish Shellfish Immunol 2002, 12: 77-95. 10.1006/fsim.2001.0356PubMedView ArticleGoogle Scholar
- Christie KE, Graham DA, McLoughlin MF, Villoing S, Todd D, Knappskog D: Experimental infection of Atlantic salmon Salmo salar pre-smolts by i.p. injection with new Irish and Norwegian salmonid alphavirus (SAV) isolates: a comparative study. Dis Aquat Organ 2007, 75: 13-22. 10.3354/dao075013PubMedView ArticleGoogle Scholar
- Wheatley SB, McLoughlin MF, Menzies FD, Goodall EA: Site management factors influencing mortality rates in Atlantic salmon ( Salmo salar L.) during marine production. Aquaculture 1995, 136: 195-207. 10.1016/0044-8486(95)01058-0View ArticleGoogle Scholar
- Fridell F, Gadan K, Sundh H, Taranger G, Glette J, Olsen RE, Sundell K, Evensen Ø: Effect of hyperoxygenation and low water flow on the primary stress response and susceptibility of Atlantic salmon Salmo salar L. to experimental challenge with IPN virus. Aquaculture 2008, 270: 23-35. 10.1016/j.aquaculture.2007.04.081View ArticleGoogle Scholar
- Kvamme BO, Oppedal F, Torgersen T, Fridell F, Sundh H, Sundell KS: Fiskevelferd - Oksygennivået viktig for oppdrettsfisken sin helse og velferd (in Norwegian). In Kyst og Havbruk 2008. Fisken og havet, særnr.2 Edited by: Boxaspen K, Dahl E, Gjøsæter J, Sunnset BH. 2008, 134-137.Google Scholar
- Breitburg DL: Effects of hypoxia, and the balance between hypoxia and enrichment, on coastal fishes and fisheries. Estuaries 2002,25(4b):767-781. 10.1007/BF02804904View ArticleGoogle Scholar
- Ellis T, North B, Scott AP, Bromage NR, Porter M, Gadd D: The relationships between stocking density and the welfare of farmed rainbow trout. J Fish Biol 2002, 61: 493-531. 10.1111/j.1095-8649.2002.tb00893.xView ArticleGoogle Scholar
- Barton BA: Stress in fishes: a diversity of responses with particular reference to changes in circulating corticosteroids. Integr Comp Biol 2002, 42: 517-525. 10.1093/icb/42.3.517PubMedView ArticleGoogle Scholar
- Johansson D, Ruohonen K, Kiessling A, Oppedal F, Stiansen JE, Kelly M, Juell JE: Effect of environmental factors on swimming depth preferences of Atlantic salmon ( Salmo salar L. ) and temporal and spatial variations in oxygen levels in sea cages at a fjord site. Aquaculture 2006, 254: 594-605. 10.1016/j.aquaculture.2005.10.029View ArticleGoogle Scholar
- Kärber G: Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch Exp Pathol Pharmakol 1931, 162: 480-483. 10.1007/BF01863914View ArticleGoogle Scholar
- Karlsen M, Yousaf MN, Villoing S, Nylund A, Rimstad E: The amino terminus of the salmonid alphavirus capsid protein is decisive for subcellular localization and inhibits cellular proliferation. Arch Virol 2010,155(8):1281-93. 10.1007/s00705-010-0717-xPubMedView ArticleGoogle Scholar
- Giovannoni SJ, Rappé MS, Vergin KL, Adair NL: 16 S rRNA genes reveal stratified open ocean bacterioplankton populations related to the Green Non-Sulfur bacteria. Proc Natl Acad Sci USA 1996,23;93(15):7979-84. 10.1073/pnas.93.15.7979View ArticleGoogle Scholar
- Duesund H, Nylund S, Watanabe K, Ottem KF, Nylund A: Characterization of a VHS virus genotype III isolated from rainbow trout ( Oncorhynchus mykiss ) at a marine site on the west coast of Norway. Virol J 2010, 7: 19. 10.1186/1743-422X-7-19PubMedPubMed CentralView ArticleGoogle Scholar
- Wallis C, Henderson M, Melnick JL: Enterovirus concentration on cellulose membranes. J Appl Microbiol 1972,23(3):476-480.Google Scholar
- Goyal SM, Gerba CP: Viradel method for detection of rotavirus from seawater. J Virol Methods 1983, 7: 279-285. 10.1016/0166-0934(83)90080-0PubMedView ArticleGoogle Scholar
- Sobsey MD, Glass JS: Poliovirus concentration from tap water with electropositive adsorbent filters. Appl Environ Microbiol 1980,40(2):201-210.PubMedPubMed CentralGoogle Scholar
- Polaczyk AL, Roberts JM, Hill VR: Evaluation of 1 MDS electropositive microfilters for simultaneous recovery of multiple microbe classes from tap water. J Microbiol Methods 2007,68(2):260-266. 10.1016/j.mimet.2006.08.007PubMedView ArticleGoogle Scholar
- Devold M, Krossøy B, Aspehaug V, Nylund A: Use of RT-PCR for diagnosis of infectious salmon anaemia virus (ISAV) in carrier sea trout Salmo trutta after experimental infection. Dis Aquat Organ 2000,40(1):9-18. 10.3354/dao040009PubMedView ArticleGoogle Scholar
- Andersen L, Bratland A, Hodneland K, Nylund A: Tissue tropism of salmonid alphaviruses (subtypes SAV1 and SAV3) in experimentally challenged Atlantic salmon ( Salmo salar L.). Arch Virol 2007,152(10):1871-83. 10.1007/s00705-007-1006-1PubMedView ArticleGoogle Scholar
- Olsvik PA, Lie KK, Jordal AE, Nilsen TO, Hordvik I: Evaluation of potential reference genes in real-time RT-PCR studies of Atlantic salmon. BMC Mol Biol 2005, 17;6: 21. 10.1186/1471-2199-6-21View ArticleGoogle Scholar
- Müller PY, Janovjak H, Miserez AR, Dobbie Z: Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002,32(6):1372-4. 1376, 1378-9PubMedGoogle Scholar
- Wendelaar Bonga SE: The stress response in fish. Physiol Rev 1997,77(3):591-625.PubMedGoogle Scholar
- Weyts FAA, Cohen N, Flik G, Verburg-van Kemenade BML: Interactions between the immune system and the hypothalamo-pituitary-interrenal axis in fish. Fish Shellfish Immunol 1999,9(1):1-20. 10.1006/fsim.1998.0170View ArticleGoogle Scholar
- Rønneseth A, Pettersen EF, Wergeland HI: Neutrophils and B-cells in blood and head kidney of Atlantic salmon (Salmo salar L.) challenged with infectious pancreatic necrosis virus (IPNV). Fish Shellfish Immunol 2006,20(4):610-620. 10.1016/j.fsi.2005.08.004PubMedView ArticleGoogle Scholar
- Ferguson HW, Roberts RJ, Richards H, Collins RO, Rice DA: Severe degenerative cardiomyopathy associated with pancreas disease in Atlantic salmon, Salmo salar L. J Fish Dis 1986, 20: 95-98. 10.1111/j.1365-2761.1986.tb00987.xView ArticleGoogle Scholar
- Rodger HM, Murphy TM, Drinan EM, Rice D: Acute skeletal myopathy in farmed Atlantic salmon, Salmo salar . Dis Aquat Organ 1991, 12: 17-23. 10.3354/dao012017View ArticleGoogle Scholar
- Houghton G, Ellis AE: Pancreas disease in Atlantic salmon: serum neutralisation and passive immunisation. Fish Shellfish Immunol 1996, 6: 465-472. 10.1006/fsim.1996.0044View ArticleGoogle Scholar
- Graham DA, Fringuelli E, Wilson C, Rowley HM, Brown A, Rodger H, McLoughlin MF, McManus C, Casey E, McCarthy LJ, Ruane NM: Prospective longitudinal studies on salmonid alphavirus infections on two Atlantic salmon farms in Ireland; evidence for viral persistence. J Fish Dis 2010,33(2):123-35. 10.1111/j.1365-2761.2009.01096.xPubMedView ArticleGoogle Scholar
- Nylund A, Plarre H, Hodneland K, Devold M, Aspehaug V, Aarseth M, Koren C, Watanabe K: Haemorrhagic smolt syndrome (HSS) in Norway: pathology and associated virus-like particles. Dis Aquat Organ 2003, 54: 15-27. 10.3354/dao054015PubMedView ArticleGoogle Scholar
- Bratland A, Nylund A: Studies on the possibility of vertical transmission of Norwegian salmonid alphavirus in production of Atlantic salmon in Norway. J Aquat Anim Health 2009,21(3):173-178. 10.1577/H08-038.1PubMedView ArticleGoogle Scholar
- Houghton G: Kinetics of infection of plasma, blood leucocytes and lymphoid tissue from Atlantic salmon Salmo salar experimentally infected with pancreas disease. Dis Aquat Organ 1995, 22: 193-198. 10.3354/dao022193View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.